1887
Research Open Access
Like 0

Abstract

BACKGROUND

HIV testing guided by indicator condition (IC) is recommended by the World Health Organization to facilitate earlier diagnosis. However, it is unclear to what extent these guidelines are followed in routine primary care (PC).

AIM

To estimate the prevalence and distribution of ICs in PC in Catalonia, Spain, identify factors associated with, and prevalence of, an HIV test being administered, or not, within 4 months of IC diagnosis and assess trends over time.

METHODS

A population-based cross-sectional study was conducted using data from the Information System for the Development of Research in Primary Care, covering 5.8 million individuals in Catalonia. We identified IC episodes recorded from 1 January 2017 to 31 August 2021 among patients aged 16–65 years. For each IC episode, we assessed whether an HIV test was performed within 4 months.

RESULTS

We identified 372,712 IC episodes; 84,694 (22.7%) led to an HIV test within 4 months. Testing was higher for: men (26.3% vs 19.4% for women); migrants (27.7% vs 21.3% for Spanish citizens); younger patients (29.2% for 16–30-year-olds vs 13.7% for those over 50 years). Testing rates were highest for episodes involving syphilis (68.4%), genital herpes (50.6%), chlamydia (48.2%) and gonorrhoea (43.1%). Factors associated with increased testing included male sex, higher socioeconomic deprivation area, presence of an acute sexually transmitted infection and multiple ICs.

CONCLUSION

Substantial gaps remain in HIV testing based on ICs in PC in Catalonia. Targeted interventions are needed to improve adherence to IC-guided testing, enabling early HIV diagnosis and treatment.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.24.2400585
2025-06-19
2025-06-23
/content/10.2807/1560-7917.ES.2025.30.24.2400585
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/24/eurosurv-30-24-2.html?itemId=/content/10.2807/1560-7917.ES.2025.30.24.2400585&mimeType=html&fmt=ahah

References

  1. Centre d’Estudis Epidemiològics sobres les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Vigilància epidemiològica del VIH i la SIDA a Catalunya Informe anual 2021 [Epidemiological Surveillance of HIV and AIDS in Catalonia – 2021 Annual Report]. Badalona. [Accessed: 19 Jan 2023]. Spanish. Available from: https://scientiasalut.gencat.cat/bitstream/handle/11351/11957/informe_vigil%C3%A0ncia_epidemiologica_infeccio_VIH_SIDA_Catalunya_2021.pdf?sequence=1&isAllowed=y
  2. European Centre for Disease Prevention and Control (ECDC) and World Health Organization Regional Office for Europe. HIV/AIDS surveillance in Europe 2023 – 2022 data. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/HIV-AIDS_surveillance_in_Europe_2023_%28_2022_data_%29_0.pdf
  3. Waters L, Fisher M, Anderson J, Wood C, Delpech V, Hill T, et al. Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med. 2011;12(5):289-98.  https://doi.org/10.1111/j.1468-1293.2010.00881.x  PMID: 21054749 
  4. Skarbinski J, Rosenberg E, Paz-Bailey G, Hall HI, Rose CE, Viall AH, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175(4):588-96.  https://doi.org/10.1001/jamainternmed.2014.8180  PMID: 25706928 
  5. Kasaie P, Radford M, Kapoor S, Jung Y, Hernandez Novoa B, Dowdy D, et al. Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain. PLoS One. 2018;13(11):e0206755.  https://doi.org/10.1371/journal.pone.0206755  PMID: 30395635 
  6. Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373(9):795-807.  https://doi.org/10.1056/NEJMoa1506816  PMID: 26192873 
  7. Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One. 2013;8(1):e52845.  https://doi.org/10.1371/journal.pone.0052845  PMID: 23341910 
  8. Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, et al. Auditing HIV testing rates across Europe: Results from the hides 2 study. PLoS One. 2015;10(11):e0140845.  https://doi.org/10.1371/journal.pone.0140845  PMID: 26560105 
  9. Lazarus JV, Hoekstra M, Raben D, Delpech V, Coenen T, Lundgren JD, HIV in Europe Initiative Steering Committee. The case for indicator condition-guided HIV screening. HIV Med. 2013;14(7):445-8.  https://doi.org/10.1111/hiv.12022  PMID: 23480600 
  10. World Health Organization (WHO) and Joint United Nations Programme on HIV/AIDS (UNAIDS). Guidance on provider-initiated HIV testing and counselling in health facilities HIV/AIDS programme. Geneva: WHO; 2007. Available from: https://iris.who.int/bitstream/handle/10665/43688/9789241595568_eng.pdf?sequence=1&isAllowed=y
  11. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352(6):570-85.  https://doi.org/10.1056/NEJMsa042657  PMID: 15703422 
  12. Walensky RP, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Sax PE, et al. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med. 2005;118(3):292-300.  https://doi.org/10.1016/j.amjmed.2004.07.055  PMID: 15745728 
  13. Joore IK, Arts DL, Kruijer MJP, Moll van Charante EP, Geerlings SE, Prins JM, et al. HIV indicator condition-guided testing to reduce the number of undiagnosed patients and prevent late presentation in a high-prevalence area: a case-control study in primary care. Sex Transm Infect. 2015;91(7):467-72.  https://doi.org/10.1136/sextrans-2015-052073  PMID: 26126531 
  14. Menacho I, Sequeira E, Muns M, Barba O, Leal L, Clusa T, et al. Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditions. HIV Med. 2013;14(S3) Suppl 3;33-7.  https://doi.org/10.1111/hiv.12064  PMID: 24033901 
  15. Agustí C, Martín-Rabadán M, Zarco J, Aguado C, Carrillo R, Codinachs R, et al. [Early diagnosis of HIV in Primary Care in Spain. Results of a pilot study based on targeted screening based on indicator conditions, behavioral criteria and region of origin]. Aten Primaria. 2018;50(3):159-65. PMID: 28629887 
  16. Espinel M, Belza MJ, Cabeza-de-Vaca C, Arranz B, Guerras JM, Garcia-Soltero J, et al. La prueba del VIH orientada por condiciones indicadoras: oportunidades perdidas para adelantar el diagnóstico de la infección en hombres que tienen sexo con hombres. [Indicator condition based HIV testing: Missed opportunities for earlier diagnosis in men who have sex with men]. Enferm Infecc Microbiol Clin (Engl Ed). 2018;36(8):465-71.  https://doi.org/10.1016/j.eimce.2018.06.003  PMID: 28993068 
  17. Lin YD, Garner SE, Lau JSY, Korman TM, Woolley IJ. Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis? QJM. 2019;112(1):17-21.  https://doi.org/10.1093/qjmed/hcy223  PMID: 30295832 
  18. Scognamiglio P, Chiaradia G, De Carli G, Giuliani M, Mastroianni CM, Aviani Barbacci S, et al. The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis. BMC Infect Dis. 2013;13(1):473.  https://doi.org/10.1186/1471-2334-13-473  PMID: 24112129 
  19. Bogers SJ, Hulstein SH, Schim van der Loeff MF, de Bree GJ, Reiss P, van Bergen JEAM, et al. Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis. EClinicalMedicine. 2021;35:100877.  https://doi.org/10.1016/j.eclinm.2021.100877  PMID: 34027336 
  20. Jordans CCE, Vasylyev M, Rae C, Jakobsen ML, Vassilenko A, Dauby N, et al. National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review. Euro Surveill. 2022;27(48):2200338.  https://doi.org/10.2807/1560-7917.ES.2022.27.48.2200338  PMID: 36695464 
  21. World Health Organization (WHO). Primary health care and HIV: convergent actions. Policy considerations for decision-makers. Geneva: WHO; 2023. Available from: https://iris.who.int/bitstream/handle/10665/371494/9789240077065-eng.pdf?sequence=1
  22. Agustí C, Montoliu A, Mascort J, Carrillo R, Almeda J, Elorza JM, et al. Missed opportunities for HIV testing of patients diagnosed with an indicator condition in primary care in Catalonia, Spain. Sex Transm Infect. 2016;92(5):387-92.  https://doi.org/10.1136/sextrans-2015-052328  PMID: 26888659 
  23. Borkan J, Eaton CB, Novillo-Ortiz D, Rivero Corte P, Jadad AR. Renewing primary care: lessons learned from the Spanish health care system. Health Aff (Millwood). 2010;29(8):1432-41.  https://doi.org/10.1377/hlthaff.2010.0023  PMID: 20679646 
  24. Spanish Ministry of Health. Guía de Recomendaciones para el diagnóstico Precoz del VIH en el ámbito sanitario [Guidelines for early HIV diagnosis in the Health-Care settings]. Madrid: Spanish Ministry of Health; 2014;1-37. Spanish. Available from: https://www.sanidad.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/docs/GuiaRecomendacionesDiagnosticoPrecozVIH.pdf
  25. FitzGerald C, Hurst S. Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics. 2017;18(1):19.  https://doi.org/10.1186/s12910-017-0179-8  PMID: 28249596 
  26. Marcelin JR, Siraj DS, Victor R, Kotadia S, Maldonado YA. The Impact of Unconscious Bias in Healthcare: How to Recognize and Mitigate It. J Infect Dis. 2019;220(220) Suppl 2;S62-73.  https://doi.org/10.1093/infdis/jiz214  PMID: 31430386 
  27. FitzGerald C, Hurst S. Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics. 2017;18(1):19. . Available from: https://pubmed.ncbi.nlm.nih.gov/28249596/ https://doi.org/10.1186/s12910-017-0179-8  PMID: 28249596 
  28. Bolíbar B, Fina Avilés F, Morros R, Garcia-Gil MM, Hermosilla E, Ramos R, et al. [SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research]. Med Clin (Barc). 2012;138(14):617-21. Spanish. PMID:22444996
  29. Recalde M, Rodríguez C, Burn E, Far M, García D, Carrere-Molina J, et al. Data Resource Profile: The Information System for Research in Primary Care (SIDIAP). Int J Epidemiol. 2022;51(6):e324-36.  https://doi.org/10.1093/ije/dyac068  PMID: 35415748 
  30. Domínguez-Berjón MF, Borrell C, Cano-Serral G, Esnaola S, Nolasco A, Pasarín MI, et al. Construcción de un índice de privación a partir de datos censales en grandes ciudades españolas (Proyecto MEDEA) [Constructing a deprivation index based on census data in large Spanish cities(the MEDEA project)]. Gac Sanit. 2008;22(3):179-87.  https://doi.org/10.1157/13123961  PMID: 18579042 
  31. Raben D, Sullivan A, Salminen M, Delpech V, Radcliffe K, Lewis M, et al. HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings Content. Copenhagen: HIV in Europe; 2015 [Accessed: 2 Jul 2021]. Available from: https://www.eurotest.org/media/0ymdzdvu/guidancepdf.pdf
  32. Agustí C, Cunillera O, Almeda J, Mascort J, Carrillo R, Olmos C, et al. Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain). HIV Med. 2022;23(8):868-79.  https://doi.org/10.1111/hiv.13270  PMID: 35285143 
  33. Tan K, Black BP. A Systematic Review of Health Care Provider-Perceived Barriers and Facilitators to Routine HIV Testing in Primary Care Settings in the Southeastern United States. J Assoc Nurses AIDS Care. 2018;29(3):357-70.  https://doi.org/10.1016/j.jana.2017.12.006  PMID: 29331504 
  34. Lord E, Stockdale AJ, Malek R, Rae C, Sperle I, Raben D, et al. Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions. HIV Med. 2017;18(4):300-4.  https://doi.org/10.1111/hiv.12430  PMID: 27535357 
  35. Page I, Phillips M, Flegg P, Palmer R. The impact of new national HIV testing guidelines at a district general hospital in an area of high HIV seroprevalence. J R Coll Physicians Edinb. 2011;41(1):9-12.  https://doi.org/10.4997/JRCPE.2011.103  PMID: 21365059 
  36. Geretti AM, Loutfy M, D’Arminio Monforte A, Latysheva I, Pérez Elías MJ, Rymer J, et al. Out of focus: tailoring the cascade of care to the needs of women living with HIV. HIV Med. 2017;18(S2) Suppl 2;3-17.  https://doi.org/10.1111/hiv.12533  PMID: 28880486 
  37. Davis T, Teaster PB, Thornton A, Watkins JF, Alexander L, Zanjani F. Primary Care Providers’ HIV Prevention Practices Among Older Adults. J Appl Gerontol. 2016;35(12):1325-42.  https://doi.org/10.1177/0733464815574093  PMID: 25736425 
  38. Guaraldi G, Borghi V, Milic J, Carli F, Cuomo G, Menozzi M, et al. The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models. Open Forum Infect Dis. 2021;8(7):ofab283.  https://doi.org/10.1093/ofid/ofab283  PMID: 34307725 
/content/10.2807/1560-7917.ES.2025.30.24.2400585
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error